Go Pro

Nutex Health (NUTX) Competitors

Nutex Health logo
$196.53 0.00 (0.00%)
Closing price 07/2/2026 04:00 PM Eastern
Extended Trading
$194.52 -2.01 (-1.02%)
As of 07/2/2026 06:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

NUTX vs. LIF, ANDG, DLO, FOUR, and YY

Should you buy Nutex Health stock or one of its competitors? MarketBeat compares Nutex Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Nutex Health include Life360 (LIF), Andersen Group (ANDG), DLocal (DLO), Shift4 Payments (FOUR), and JOYY (YY). These companies are all part of the "business services" industry.

How does Nutex Health compare to Life360?

Nutex Health (NASDAQ:NUTX) and Life360 (NASDAQ:LIF) are both business services companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, risk, profitability, media sentiment, institutional ownership and earnings.

Life360 has a net margin of 28.21% compared to Nutex Health's net margin of 10.95%. Nutex Health's return on equity of 23.50% beat Life360's return on equity.

Company Net Margins Return on Equity Return on Assets
Nutex Health10.95% 23.50% 10.47%
Life360 28.21%6.80%3.65%

5.3% of Nutex Health shares are owned by institutional investors. Comparatively, 20.0% of Life360 shares are owned by institutional investors. 44.7% of Nutex Health shares are owned by insiders. Comparatively, 6.8% of Life360 shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Life360 has lower revenue, but higher earnings than Nutex Health. Nutex Health is trading at a lower price-to-earnings ratio than Life360, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nutex Health$875.26M1.54$70.79M$12.9415.19
Life360$528.98M8.84$150.83M$1.7333.36

Nutex Health has a beta of 0.21, suggesting that its stock price is 79% less volatile than the broader market. Comparatively, Life360 has a beta of 2.34, suggesting that its stock price is 134% more volatile than the broader market.

Nutex Health currently has a consensus target price of $243.33, indicating a potential upside of 23.81%. Life360 has a consensus target price of $64.17, indicating a potential upside of 11.19%. Given Nutex Health's stronger consensus rating and higher possible upside, equities analysts clearly believe Nutex Health is more favorable than Life360.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nutex Health
0 Sell rating(s)
2 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.60
Life360
1 Sell rating(s)
4 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.55

In the previous week, Life360 had 4 more articles in the media than Nutex Health. MarketBeat recorded 8 mentions for Life360 and 4 mentions for Nutex Health. Nutex Health's average media sentiment score of 0.94 beat Life360's score of 0.22 indicating that Nutex Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Nutex Health
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Life360
2 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Life360 beats Nutex Health on 9 of the 17 factors compared between the two stocks.

How does Nutex Health compare to Andersen Group?

Nutex Health (NASDAQ:NUTX) and Andersen Group (NYSE:ANDG) are both business services companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, risk, profitability, valuation, dividends, institutional ownership, earnings and media sentiment.

Nutex Health has higher revenue and earnings than Andersen Group. Nutex Health is trading at a lower price-to-earnings ratio than Andersen Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nutex Health$875.26M1.54$70.79M$12.9415.19
Andersen Group$838.69M4.91-$2.32M$0.17214.71

In the previous week, Nutex Health had 4 more articles in the media than Andersen Group. MarketBeat recorded 4 mentions for Nutex Health and 0 mentions for Andersen Group. Nutex Health's average media sentiment score of 0.94 beat Andersen Group's score of 0.00 indicating that Nutex Health is being referred to more favorably in the media.

Company Overall Sentiment
Nutex Health Positive
Andersen Group Neutral

Nutex Health has a net margin of 10.95% compared to Andersen Group's net margin of 0.00%. Nutex Health's return on equity of 23.50% beat Andersen Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Nutex Health10.95% 23.50% 10.47%
Andersen Group N/A N/A N/A

5.3% of Nutex Health shares are owned by institutional investors. 44.7% of Nutex Health shares are owned by company insiders. Comparatively, 13.0% of Andersen Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Nutex Health presently has a consensus price target of $243.33, indicating a potential upside of 23.81%. Andersen Group has a consensus price target of $39.00, indicating a potential upside of 6.85%. Given Nutex Health's stronger consensus rating and higher possible upside, equities research analysts plainly believe Nutex Health is more favorable than Andersen Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nutex Health
0 Sell rating(s)
2 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.60
Andersen Group
1 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.56

Summary

Nutex Health beats Andersen Group on 12 of the 16 factors compared between the two stocks.

How does Nutex Health compare to DLocal?

Nutex Health (NASDAQ:NUTX) and DLocal (NASDAQ:DLO) are both business services companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, valuation, earnings, profitability, dividends, risk, analyst recommendations and institutional ownership.

Nutex Health has a beta of 0.21, meaning that its stock price is 79% less volatile than the broader market. Comparatively, DLocal has a beta of 0.97, meaning that its stock price is 3% less volatile than the broader market.

DLocal has higher revenue and earnings than Nutex Health. Nutex Health is trading at a lower price-to-earnings ratio than DLocal, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nutex Health$875.26M1.54$70.79M$12.9415.19
DLocal$1.09B4.01$196.80M$0.6323.62

In the previous week, DLocal had 4 more articles in the media than Nutex Health. MarketBeat recorded 8 mentions for DLocal and 4 mentions for Nutex Health. Nutex Health's average media sentiment score of 0.94 beat DLocal's score of 0.35 indicating that Nutex Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Nutex Health
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
DLocal
2 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral

Nutex Health presently has a consensus target price of $243.33, indicating a potential upside of 23.81%. DLocal has a consensus target price of $17.25, indicating a potential upside of 15.93%. Given Nutex Health's higher probable upside, equities research analysts plainly believe Nutex Health is more favorable than DLocal.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nutex Health
0 Sell rating(s)
2 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.60
DLocal
0 Sell rating(s)
1 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
3.00

DLocal has a net margin of 15.85% compared to Nutex Health's net margin of 10.95%. DLocal's return on equity of 41.22% beat Nutex Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Nutex Health10.95% 23.50% 10.47%
DLocal 15.85%41.22%14.27%

5.3% of Nutex Health shares are held by institutional investors. Comparatively, 90.1% of DLocal shares are held by institutional investors. 44.7% of Nutex Health shares are held by insiders. Comparatively, 45.4% of DLocal shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

DLocal beats Nutex Health on 14 of the 17 factors compared between the two stocks.

How does Nutex Health compare to Shift4 Payments?

Nutex Health (NASDAQ:NUTX) and Shift4 Payments (NYSE:FOUR) are both business services companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, profitability, valuation, risk, media sentiment, analyst recommendations and institutional ownership.

Nutex Health has a beta of 0.21, meaning that its share price is 79% less volatile than the broader market. Comparatively, Shift4 Payments has a beta of 1.41, meaning that its share price is 41% more volatile than the broader market.

Nutex Health currently has a consensus price target of $243.33, indicating a potential upside of 23.81%. Shift4 Payments has a consensus price target of $68.29, indicating a potential upside of 33.28%. Given Shift4 Payments' higher probable upside, analysts clearly believe Shift4 Payments is more favorable than Nutex Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nutex Health
0 Sell rating(s)
2 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.60
Shift4 Payments
1 Sell rating(s)
12 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.39

In the previous week, Shift4 Payments had 3 more articles in the media than Nutex Health. MarketBeat recorded 7 mentions for Shift4 Payments and 4 mentions for Nutex Health. Nutex Health's average media sentiment score of 0.94 beat Shift4 Payments' score of 0.61 indicating that Nutex Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Nutex Health
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Shift4 Payments
2 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Shift4 Payments has higher revenue and earnings than Nutex Health. Nutex Health is trading at a lower price-to-earnings ratio than Shift4 Payments, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nutex Health$875.26M1.54$70.79M$12.9415.19
Shift4 Payments$4.18B0.97$119M$0.8460.99

5.3% of Nutex Health shares are owned by institutional investors. Comparatively, 98.9% of Shift4 Payments shares are owned by institutional investors. 44.7% of Nutex Health shares are owned by company insiders. Comparatively, 1.5% of Shift4 Payments shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Nutex Health has a net margin of 10.95% compared to Shift4 Payments' net margin of 2.63%. Shift4 Payments' return on equity of 33.55% beat Nutex Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Nutex Health10.95% 23.50% 10.47%
Shift4 Payments 2.63%33.55%5.01%

Summary

Shift4 Payments beats Nutex Health on 9 of the 16 factors compared between the two stocks.

How does Nutex Health compare to JOYY?

Nutex Health (NASDAQ:NUTX) and JOYY (NASDAQ:YY) are both business services companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, valuation, analyst recommendations, media sentiment, profitability and earnings.

In the previous week, Nutex Health had 3 more articles in the media than JOYY. MarketBeat recorded 4 mentions for Nutex Health and 1 mentions for JOYY. JOYY's average media sentiment score of 2.00 beat Nutex Health's score of 0.94 indicating that JOYY is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Nutex Health
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
JOYY
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Nutex Health has a beta of 0.21, indicating that its stock price is 79% less volatile than the broader market. Comparatively, JOYY has a beta of 0.21, indicating that its stock price is 79% less volatile than the broader market.

JOYY has higher revenue and earnings than Nutex Health. JOYY is trading at a lower price-to-earnings ratio than Nutex Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nutex Health$875.26M1.54$70.79M$12.9415.19
JOYY$2.24B1.62$301.82M-$3.10N/A

5.3% of Nutex Health shares are held by institutional investors. Comparatively, 36.8% of JOYY shares are held by institutional investors. 44.7% of Nutex Health shares are held by insiders. Comparatively, 43.0% of JOYY shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Nutex Health has a net margin of 10.95% compared to JOYY's net margin of 9.02%. Nutex Health's return on equity of 23.50% beat JOYY's return on equity.

Company Net Margins Return on Equity Return on Assets
Nutex Health10.95% 23.50% 10.47%
JOYY 9.02%4.64%2.96%

Nutex Health presently has a consensus target price of $243.33, indicating a potential upside of 23.81%. JOYY has a consensus target price of $66.00, indicating a potential downside of 1.87%. Given Nutex Health's higher possible upside, research analysts clearly believe Nutex Health is more favorable than JOYY.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nutex Health
0 Sell rating(s)
2 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.60
JOYY
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

Nutex Health beats JOYY on 8 of the 15 factors compared between the two stocks.

Get Nutex Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for NUTX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NUTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NUTX vs. The Competition

MetricNutex HealthMedical Services IndustryMedical SectorNASDAQ Exchange
Market Cap$1.35B$9.63B$7.18B$12.46B
Dividend YieldN/A1.62%2.67%6.49%
P/E Ratio15.1927.8427.7524.70
Price / Sales1.5418.52533.8298.65
Price / Cash15.22114.6949.2657.09
Price / Book3.286.1910.966.46
Net Income$70.79M$179.69M$3.57B$337.01M
7 Day Performance18.11%3.82%2.11%1.70%
1 Month Performance45.47%9.13%2.80%0.68%
1 Year Performance64.60%14.53%33.39%23.94%

Nutex Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NUTX
Nutex Health
3.6189 of 5 stars
$196.53
flat
$243.33
+23.8%
+64.6%$1.35B$875.26M15.191,150
LIF
Life360
2.354 of 5 stars
$54.13
-6.0%
$64.17
+18.5%
-12.2%$4.39B$489.48M31.30600
ANDG
Andersen Group
3.0401 of 5 stars
$36.39
-4.1%
$39.00
+7.2%
N/A$4.11B$871.37MN/A2,300
DLO
DLocal
4.6917 of 5 stars
$12.79
-0.5%
$16.63
+30.0%
+29.4%$3.77B$1.09B20.311,274
FOUR
Shift4 Payments
4.7239 of 5 stars
$47.20
-2.1%
$68.29
+44.7%
-49.7%$3.74B$4.18B56.076,300

Related Companies and Tools


This page (NASDAQ:NUTX) was last updated on 7/4/2026 by MarketBeat.com Staff.
From Our Partners